A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma
NCT06235229
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
GC012F
Sponsor
Gracell Biotechnologies (Shanghai) Co., Ltd.